| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/16/2010 | US7662585 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 02/16/2010 | US7662387 administering a conjugate of antibody ( humanized, chimeric or constant region) and a drug such as fetoprotein/alpha-/, monomethyl auristatin E or monomethyl auristatin F to treat CD70-expressing cancer selected from a kidney tumor, a B cell lymphoma, a thymic carcinoma, and a nasopharyngeal carcinoma |
| 02/16/2010 | US7662382 Inducible ligand for α1β1 integrin and uses |
| 02/16/2010 | CA2503029C Process for synthesizing l-.gamma.-methylene glutamic acid and analogs |
| 02/16/2010 | CA2385938C Cyclic amine compounds as ccr5 antagonists |
| 02/16/2010 | CA2220433C Il-6 activity inhibitor |
| 02/11/2010 | US20100036097 Mutant Interleukin-2 (IL-2) Polypeptides |
| 02/11/2010 | US20100035891 Pharmaceutically Active Compounds |
| 02/11/2010 | US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 02/11/2010 | US20100034741 Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor |
| 02/10/2010 | CN100588423C Controlled release compositions |
| 02/09/2010 | CA2482320C Methods for modulating phototoxicity |
| 02/09/2010 | CA2416792C Crystalline and pure modafinil, and process of preparing the same |
| 02/09/2010 | CA2386297C Bicyclic amino acids as pharmaceutical agents |
| 02/09/2010 | CA2286614C Plant extracts for the treatment of increased bone resorption |
| 02/09/2010 | CA2274201C Di-or triaza-spiro[4,5]decane derivatives |
| 02/04/2010 | WO2004016219A9 Clinical assays for the detection and typing of human herpesviruses |
| 02/04/2010 | US20100029973 Fatty acid analogues for equilibrating bone mineral density |
| 02/04/2010 | US20100029897 Anion-binding polymers and uses thereof |
| 02/04/2010 | US20100029639 Ion channel modulating compounds and uses thereof |
| 02/03/2010 | CN100586484C Thorium-227 for use in radiotherapy of soft tissue disease |
| 02/02/2010 | US7657313 Adaptive cardiac resynchronization therapy system |
| 02/02/2010 | US7655772 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 02/02/2010 | US7655681 Administering zonisamide; clearing mucus; protective patches |
| 02/02/2010 | US7655231 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID |
| 02/02/2010 | US7655217 Using water soluble dyes; fluorescence contrast agent |
| 02/02/2010 | US7654948 Automated insomnia treatment system |
| 02/02/2010 | CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 01/28/2010 | WO2006130401A3 Method and apparatus for providing light to blood |
| 01/28/2010 | US20100021484 Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccines |
| 01/28/2010 | US20100021475 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 01/28/2010 | US20100021461 Immunoglobulin formulation and method of preparation thereof |
| 01/27/2010 | EP2147930A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147929A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147928A2 Peptide-based immunization therapy for treatment of atherosclerososis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147680A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2025227B1 Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 01/27/2010 | EP1704227B1 Immortalized hepatocytes |
| 01/27/2010 | CN101633655A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 01/27/2010 | CN101633636A Peptidomimetic protease inhibitors |
| 01/27/2010 | CN100584335C Composition and uses for treatment of reactive arthritis or bursitis |
| 01/27/2010 | CN100584322C Compositions comprising modafinil compounds |
| 01/27/2010 | CN100584321C Vaginal health products |
| 01/26/2010 | US7652033 HIF-1 inhibitors |
| 01/26/2010 | US7651846 Treatment and diagnosis of conditions associated with elevated arginase activity |
| 01/26/2010 | CA2529374C Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
| 01/21/2010 | WO2004034969A9 Functional sites |
| 01/21/2010 | WO2004024097A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | WO2003061561A9 Epsilon immunoglobulin chain derived peptides for induction of anti-ige antibodies |
| 01/21/2010 | US20100016385 Process and formulation containing epothilones and analogs thereof |
| 01/21/2010 | US20100016320 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 01/21/2010 | US20100015117 Compositions and methods for targeting a polypeptide to the central nervous system |
| 01/21/2010 | US20100015047 Lung-Expressed Polypeptides |
| 01/19/2010 | US7648997 Immunomodulators for inducing cytokine biosynthesis, for treatment of diseases including viral and neoplastic diseases; 1-[3-(Aminooxy)propyl]-2-propyl-1H-imidazo[4,5-c]quinolin-4-amine; N-[3-(4-Amino-2-propyl-1H-imidazo[4,5-c]quinolin-1-yl)propoxy]cyclopropanecarboxamide |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/19/2010 | US7648712 Fast dissolving orally consumable films containing a taste masking agent |
| 01/19/2010 | CA2465928C Synthesis and purification of valacyclovir |
| 01/19/2010 | CA2373255C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 01/19/2010 | CA2183620C Sustained release composition |
| 01/14/2010 | WO2005041874A9 Method and antisense composition for selective inhibition of hiv infection in hematopoietic cells |
| 01/13/2010 | EP2143727A1 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 01/13/2010 | EP1558749B1 Atypical protein kinase c isoforms in disorders of the nervous system and cancer |
| 01/13/2010 | CN100579976C P38 inhibitors and methods of use thereof |
| 01/12/2010 | US7645784 Benzimidazole derivatives |
| 01/12/2010 | US7645761 Indoline derivatives |
| 01/12/2010 | CA2545128C Methods and compositions using thalidomide for the treatment and management of cancers and other diseases |
| 01/12/2010 | CA2528064C Low dose pharmaceutical powders for inhalation |
| 01/12/2010 | CA2481461C Derivatives of n-[phenyl(piperidin-2-yl) methyl] benzamide, the preparation method thereof and application of same in therapeutics |
| 01/12/2010 | CA2461946C Combinations for the treatment of immunoinflammatory disorders |
| 01/12/2010 | CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/07/2010 | US20100004276 Vitamin receptor binding drug delivery conjugates |
| 01/07/2010 | US20100003355 Jucara and acai fruit-based compositions |
| 01/07/2010 | US20100003310 Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
| 01/06/2010 | EP2140878A1 Vaccine against streptococcus pneumoniae |
| 01/06/2010 | EP2140875A1 Compositions and methods for healthy pregnancy |
| 01/06/2010 | EP2140864A2 Use of GAL3 receptor antagonists for the treatment of depression and / or anxiety and compounds useful in such methods |
| 01/06/2010 | EP2140862A2 Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods |
| 01/06/2010 | EP1575565B1 Modified-release tablet of bupropion hydrochloride |
| 01/06/2010 | CN100577206C Controlled release composition and method of producing the same |
| 01/06/2010 | CN100577148C Pharmaceutical composition comprising N((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and preparation process therefor comprising dry granulation |
| 01/05/2010 | US7642255 Compounds and compositions as protein kinase inhibitors |
| 01/05/2010 | US7641898 cells are dispersed using an air-jet sprayer after being suspended in a soluble media either directly onto the area or onto a tissue scaffold to form three dimensional epithelial tissue |
| 01/05/2010 | CA2426467C Composition comprising 8-prenylnaringenin for treatment of skin |
| 12/31/2009 | US20090326604 Systems and methods for altering vestibular biology |
| 12/31/2009 | US20090326233 4-phenylpiperidine compounds |
| 12/31/2009 | US20090326221 New oxabispidine compunds useful in the treatment of cardiac arrhythmias |
| 12/31/2009 | US20090326039 Inhibitors for the soluble epoxide hydrolase |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090325909 Suppression of HIV replication and prevention and treatment of HIV |
| 12/31/2009 | US20090325858 Reduction of Zinc-Induced Neurotoxic Injury By Blockade of Nitric Oxide Synthesis |
| 12/31/2009 | US20090324643 Compositions and methods for treating and preventing infection |
| 12/31/2009 | US20090324598 Method for the treatment of inflammatory disorders |
| 12/31/2009 | US20090324542 optic neuritis; fingolimod or 2-amino-2-{2-[4-(1-oxo-5-phenylpentyl)phenyl]ethyl}propane-1,3-diol or salts as SP1 agonist |
| 12/31/2009 | US20090324493 Method for preparing a saline solution comprising [13n] nh4 + and use of a device |
| 12/30/2009 | EP2138190A2 Compositions comprising dietary fat complexer and methods for their use |
| 12/30/2009 | EP2138179A1 Use of cytidine derivatives for the treatment of leukaemia |
| 12/30/2009 | EP1678161B1 Thioether-substituted benzamides as inhibitors of factor xa |
| 12/30/2009 | CN101612401A Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 12/30/2009 | CN100575955C Un-expression of protein as marker of tumor transfer |
| 12/30/2009 | CN100575482C Novel cytokine zcytor17 ligand |